Cargando…
Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
Introduction: Advances in the biology of non-small-cell lung cancer, especially adenocarcinoma, reveal multiple molecular subtypes driving oncogenesis. Accordingly, individualized targeted therapeutics are based on mutational diagnostics. Areas covered: Advances in strategies and techniques for indi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926789/ https://www.ncbi.nlm.nih.gov/pubmed/27139190 http://dx.doi.org/10.1080/14737159.2016.1181545 |